Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acemetacin SR in Active Axial Spondyloarthritis (Real-World, Observational)
ChiCTR2600123028Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acemetacin in axial spondyloarthritis (axSpA), sponsored by Chinese PLA General Hospital. Primary endpoint: Overall pain score (Visual Analogue Scale). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
acemetacin
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on ChiCTR2600123028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123028.